Roche late Friday released results from two Phase III studies - dubbed MEERKAT and SANDCAT - evaluating the efficacy and ...

Isotope Technologies Munich (ITM) has announced a higher objective response rate (ORR) and prolonged median progression-free ...

USA-based Praxis Precision Medicines, a biopharma translating genetic insights into the development of therapies for central ...

New York-based Immunai, a biotech that uses single-cell genomics and machine learning to discover and improve development of ...

The European Medicine Agency’s (EMA) human medicines committee (CHMP) recommended two novel medicines for approval at its ...

Shares of China’s Hansoh Pharmaceutical edged up 2% to HK$36.50 as it announced a license agreement with Roche for HS-20110, ...

Chinese biotech Kelun-Biotech (HKEX: 6990) has gained approval from the National Medical Products Administration for ...

Anglo-Swedish pharma major AstraZeneca (LSE: AZN) has presented new data showing the impact of its PD-L1 inhibitor Imfinzi ...

US hematology specialist Disc Medicine surged 19.7% in after-hours trading Thursday after the company announced it received a ...

US pharma major Eli Lilly has announced results from the primary overall survival (OS) analysis of the Phase III monarchE ...

USA-based clinical-stage dermatology start-up Veradermics has announced the completion of an oversubscribed $150 million ...

German pharma group Merck (MRK: DE) has become the third company to strike a cost-cutting agreement with the Trump ...